413 related articles for article (PubMed ID: 24373326)
21. Assessing the role of subconjunctival versus intrascleral application of mitomycin C in high-risk trabeculectomies.
Agarwal HC; Saigal D; Sihota R
Indian J Ophthalmol; 2001 Jun; 49(2):91-5. PubMed ID: 15884512
[TBL] [Abstract][Full Text] [Related]
22. Visante anterior segment optical coherence tomography analysis of morphologic changes after deep sclerectomy with intraoperative mitomycin-C and no implant use.
Pérez-Rico C; Gutiérrez-Ortíz C; Moreno-Salgueiro A; González-Mesa A; Teus MA
J Glaucoma; 2014 Jan; 23(1):e86-90. PubMed ID: 24370813
[TBL] [Abstract][Full Text] [Related]
23. Deep sclerectomy with bevacizumab and mitomycin C: a comparative study.
Anand N; Bong C
J Glaucoma; 2015 Jan; 24(1):25-31. PubMed ID: 23429630
[TBL] [Abstract][Full Text] [Related]
24. Long-Term Outcomes of Trabeculectomy Augmented with Mitomycin C Undertaken within the First 2 Years of Life.
Jayaram H; Scawn R; Pooley F; Chiang M; Bunce C; Strouthidis NG; Khaw PT; Papadopoulos M
Ophthalmology; 2015 Nov; 122(11):2216-22. PubMed ID: 26315044
[TBL] [Abstract][Full Text] [Related]
25. Comparison of low-dose intraoperative mitomycin-C vs 5-fluorouracil in primary glaucoma surgery: a pilot study.
Vijaya L; Mukhesh BN; Shantha B; Ramalingam S; Sathi Devi AV
Ophthalmic Surg Lasers; 2000; 31(1):24-30. PubMed ID: 10976557
[TBL] [Abstract][Full Text] [Related]
26. Baerveldt tube implantation following failed deep sclerectomy versus repeat deep sclerectomy.
Bergin C; Petrovic A; Mermoud A; Ravinet E; Sharkawi E
Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):161-8. PubMed ID: 26520444
[TBL] [Abstract][Full Text] [Related]
27. Amniotic membrane transplantation in trabeculectomy with mitomycin C for refractory glaucoma.
Sheha H; Kheirkhah A; Taha H
J Glaucoma; 2008; 17(4):303-7. PubMed ID: 18552616
[TBL] [Abstract][Full Text] [Related]
28. Role of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1-year follow-up study.
Akkan JU; Cilsim S
J Glaucoma; 2015 Jan; 24(1):1-8. PubMed ID: 23661044
[TBL] [Abstract][Full Text] [Related]
29. Prospective evaluation of CO
Cutolo CA; Bagnis A; Scotto R; Bonzano C; Traverso CE
Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):181-186. PubMed ID: 29147757
[TBL] [Abstract][Full Text] [Related]
30. Use of a Collagen Matrix Implant as an Adjuvant in Combined Surgery Involving Phacoemulsification and Nonpenetrating Deep Sclerectomy.
Paletta Guedes RA; Gravina DM; Paletta Guedes VM; Chaoubah A
J Glaucoma; 2019 Apr; 28(4):363-366. PubMed ID: 30628996
[TBL] [Abstract][Full Text] [Related]
31. Primary phakic deep sclerectomy augmented with mitomycin C: long-term outcomes.
Anand N; Kumar A; Gupta A
J Glaucoma; 2011 Jan; 20(1):21-7. PubMed ID: 20179623
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of Adjunctive Subconjunctival Bevacizumab on the Outcomes of Primary Trabeculectomy With Mitomycin C: A Prospective Randomized Placebo-controlled Trial.
Kiddee W; Orapiriyakul L; Kittigoonpaisan K; Tantisarasart T; Wangsupadilok B
J Glaucoma; 2015; 24(8):600-6. PubMed ID: 25393038
[TBL] [Abstract][Full Text] [Related]
33. Deep sclerectomy with supraciliary hema implant (Esnoper® V-2000): results and complications.
Loscos J; Valldeperas X; Langohr K; Parera À; Romera P; Sabala A; de la Cámara J
Int Ophthalmol; 2015 Oct; 35(5):693-9. PubMed ID: 25633644
[TBL] [Abstract][Full Text] [Related]
34. Nonpenetrating very deep sclerectomy with reticulated hyaluronic acid implant in glaucoma treatment.
Leszczyński R; Gierek-Ciaciura S; Forminśka-Kapuścik M; Mrukwa-Kominek E; Rokita-Wala I
Med Sci Monit; 2008 Feb; 14(2):CR86-89. PubMed ID: 18227766
[TBL] [Abstract][Full Text] [Related]
35. Long-term results of deep sclerectomy with collagen implant.
Shaarawy T; Mansouri K; Schnyder C; Ravinet E; Achache F; Mermoud A
J Cataract Refract Surg; 2004 Jun; 30(6):1225-31. PubMed ID: 15177596
[TBL] [Abstract][Full Text] [Related]
36. Two-year Results After Deep Sclerectomy With Nonabsorbable Uveoscleral Implant (Esnoper-Clip): Surgical Area Analysis Using Anterior Segment Optical Coherence Tomography.
Romera-Romero P; Loscos-Arenas J; Moll-Udina A; Romanic-Bubalo N; Castellvi-Manent J; Valldeperas X
J Glaucoma; 2017 Oct; 26(10):929-935. PubMed ID: 28991150
[TBL] [Abstract][Full Text] [Related]
37. Surgical revision of failed filtration surgery with mitomycin C augmentation.
Anand N; Arora S
J Glaucoma; 2007 Aug; 16(5):456-61. PubMed ID: 17700288
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the effect of mitomycin C and bevacizumab-methylcellulose mixture on combined phacoemulsification and non-penetrating deep sclerectomy surgery on the intraocular pressure (a clinical trial study).
Mostafaei A; Taheri N; Ghojazadeh M; Latifi A; Moghaddam N
Int Ophthalmol; 2019 Oct; 39(10):2341-2351. PubMed ID: 30656509
[TBL] [Abstract][Full Text] [Related]
39. Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma.
Kozobolis VP; Christodoulakis EV; Tzanakis N; Zacharopoulos I; Pallikaris IG
J Glaucoma; 2002 Aug; 11(4):287-93. PubMed ID: 12169964
[TBL] [Abstract][Full Text] [Related]
40. Intraindividual comparison of Canaloplasty versus trabeculectomy with mitomycin C in a single-surgeon series.
Brüggemann A; Despouy JT; Wegent A; Müller M
J Glaucoma; 2013 Sep; 22(7):577-83. PubMed ID: 23632395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
